Remove Clinical Trials Remove Environment Remove Patients Remove Safety
article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. Forward-looking statements are only predictions.

article thumbnail

Position: Atai – Director/Manager Regulatory Affairs (f/m/d)

Cannabis Law Report

A fast-paced environment where you’ll work on a wide range of topics. Become part of creating a radically new and impactful paradigm shift in drug development and patient care. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus. Position: Full-time. Opportunity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Press Release: Launch of the Psychedelic Access and Research European Alliance – PAREA

Cannabis Law Report

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access 52
article thumbnail

Position -Atai: Director/Manager Regulatory Affairs

Cannabis Law Report

A fast-paced environment where you’ll work on a wide range of topics. Become part of creating a radically new and impactful paradigm shift in drug development and patient care. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus. Position: Full-time. Opportunity.

article thumbnail

New Zealand Govt Consultation Doc Says “Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand”

Cannabis Law Report

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. From trial to market. Finally, the medicine moves into “efficacy” trials. This is the first time it is given to patients.

article thumbnail

Do you trust your doctor about cannabis?

The Cannigma

The dualistic narratives of cannabis reflect the lack of a dominant narrative environment that supports the integration of cannabis into medical practice.”. The paper concluded that the “lack of a dominant narrative environment” on the efficacy of medical marijuana can represent a barrier to the implementation of medical cannabis policies.

Education 101
article thumbnail

India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

Cannabis Law Report

He played a leadership role in the areas of defense, health, and the environment. We look forward to his guidance in helping us bring new, THC-based investigational medications into FDA approved clinical trials. He served on the Appropriation, Banking and Finance and Budget committees. www.igcinc.us , www.igcpharma.com.